Regulus Announces Strategic Update and Corporate Restructuring

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. MRVL
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. AMD
9. CHRW
10. STZ

Go back to Regulus Announces Strategic Update and Corporate Restructuring

Regulus Therapeutics (RGLS) PT Lowered to $0.50 at Wells Fargo

July 6, 2018 8:27 AM EDT

Wells Fargo analyst Jim Birchenough lowered his price target on Regulus Therapeutics (NASDAQ: RGLS) to $0.50 (from $1.50) while maintaining a Market Perform rating following todays interruption of the phase 1 study of anti-miR therapeutic RGLS4326 in autosomal dominant polycystic kidney disease (ADPKD) following unexpected preclinical... More

Regulus Therapeutics (RGLS) Falls 38% as Trading Resumes

July 5, 2018 5:33 PM EDT

Regulus Therapeutics (NASDAQ: RGLS) sinks 38% as trading resumes following restructuring and massive job cuts.

... More

Regulus Therapeutics (RGLS) to Resume Trading at 5:30 pm ET

July 5, 2018 5:03 PM EDT

Regulus Therapeutics (NASDAQ: RGLS) to Resume Trading at 5:30 pm ET

... More